E. Guiard

Most-cited papers

1. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma.

   E. Guiard, F. Clatot, C. Even, M. Perréard +4 more

   2021European Journal of Cancer19 citations Open access

   Semantic Scholar

   Save

2. Retrospective multicentric survival analysis of patients receiving TPEx regimen as first-line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma

   L. Libert, C. Abdeddaim, K. Saleh, C. Even +9 more

   2025ESMO Open5 citations Open access

   Semantic Scholar

   Save

3. Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs.

   E. Guiard, C. Baldini, C. Pobel, T. Assi +10 more

   2022European Journal of Cancer3 citations Open access

   Semantic Scholar

   Save

4. 886P Retrospective multicentric survival analysis of patients receiving TPEx regimen (docetaxel, platinum and cetuximab) as first line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck

   L. Libert, C. Abdeddaim, K. Saleh, C. Even +9 more

   2024Annals of Oncology0 citations Open access

   Semantic Scholar

   Save